Replies to post #32604 on Ariad Pharmaceuticals Inc fka ARIA

[iandy]

A 30mg dose for treatment naive patients could be advantageous in several respects. In addition to the probable safety advantage, they could price the drug more competitively, negate impediments to first line approvals in Europe and in the US, and grab more worldwide market share.

[piece o mind]

how much longer until the market factors in these potentials?